Phathom Pharmaceuticals, Inc. (PHAT) stock
PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.06−0.17 (-2.73%)
Close on Nov 13, 2026Market cap $492.63MP/E –Yield –
Phathom Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Phathom Pharmaceuticals's enterprise value was $484.95M on Nov 11, 2026, against $1.18B a year earlier. Over the last 5 years it ranged from $198.09M to $1.25B, with a median of $436.31M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $484.95M | -61.2% |
| 2025 | Dec 31, 2025 | $1.25B | +215.9% |
| 2024 | Dec 31, 2024 | $395.84M | -2.1% |
| 2023 | Dec 29, 2023 | $404.25M | +12.7% |
| 2022 | Dec 30, 2022 | $358.67M | -21.1% |
| 2021 | Dec 31, 2021 | $454.72M | -33.2% |
| 2020 | Dec 31, 2020 | $681.19M | +335.0% |
| 2019 | Dec 31, 2019 | $156.61M | – |
See a number that looks wrong?